2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Breast Neoplasms
327
Neoplasm Metastasis
40
Neoplasms
25
Advanced Breast Cancer
19
Ovarian Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Endometrial Neoplasms
11
Prostatic Neoplasms
10
Hereditary Sensory and Autonomic Neuropathies
10
Triple Negative Breast Neoplasms
8
Colorectal Neoplasms
6
Breast Cancer Metastatic
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Multiple Endocrine Neoplasia Type 1
5
Carcinoma, Ovarian Epithelial
5
Breast Diseases
5
Neoplasms by Site
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Lobular
3
Breast Neoplasm Female
3
Uterine Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Interventions
Ifosfamide
3
Doxorubicin
3
Radiotherapy
2
Imatinib Mesylate
2
Filgrastim
2
trebananib
1
selurampanel
1
selinexor
1
saracatinib
1
perifosine
1
elacestrant
1
Trabectedin
1
Thalidomide
1
Temozolomide
1
Sunitinib
1
RAD1901
1
Postmortem Imaging
1
Paclitaxel
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
High-Energy Shock Waves
1
Fulvestrant
1
Cyproheptadine
1
Chromatography, High Pressure Liquid
1
Chemotherapy, Adjuvant
1
Biopsy
1
BI 2536
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Endometrial Stromal
×
Fulvestrant
×
Clear all
NCT03926936
2024-05-28
FUCHSia
University Hospital, Gasthuisberg
Phase 2
Completed
17 enrolled